| Onyx Biotec Ltd | Industry : Pharmaceuticals | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 |
|---|---|---|---|---|
| Debt-Equity Ratio | 0.53 | 1.38 | 1.20 | 0.75 |
| Long Term Debt-Equity Ratio | 0.38 | 0.96 | 0.77 | 0.53 |
| Current Ratio | 1.45 | 0.93 | 0.87 | 1.26 |
| Fixed Assets | 1.23 | 0.92 | 0.91 | 1.48 |
| Inventory | 4.92 | 6.97 | 8.42 | 14.71 |
| Debtors | 3.48 | 5.26 | 5.85 | 5.33 |
| Interest Cover Ratio | 3.73 | 3.08 | 5.46 | 6.83 |
| PBIDTM (%) | 17.11 | 15.85 | 11.67 | 13.13 |
| PBITM (%) | 12.19 | 12.37 | 7.90 | 9.90 |
| PBDTM (%) | 13.85 | 11.83 | 10.23 | 11.68 |
| CPM (%) | 11.74 | 10.23 | 8.43 | 10.70 |
| APATM (%) | 6.81 | 6.75 | 4.66 | 7.47 |
| ROCE (%) | 12.15 | 12.80 | 8.09 | 15.32 |
| RONW (%) | 10.43 | 16.69 | 10.65 | 20.46 |